Low-Sodium Xywav Leads Jazz Pharma’s Oxybate Revenues

During the second quarter, Jazz Pharmaceuticals registered a 39% year-over-year growth in net product sales of its low-sodium Xywav, reflecting its rising adoption, according to the company’s latest financial results and business highlights. More than 50% of Jazz’s oxybate revenues are now driven by Xywav, a treatment for narcolepsy and idiopathic hypersomnia (IH). The drug…

Read More

Obesity a ‘Significant Predictor’ of Sleep Apnea Severity in Kids

Obesity is a significant predictor for obstructive sleep apnea (OSA) severity in children, while older age is a risk factor for residual OSA, researchers at UT Southwestern Medical Center and Children’s Health found.  Published in Laryngoscope Investigative Otolaryngology, the study adds to the growing awareness of obesity’s role in pediatric OSA and its associated effects…

Read More

Believers in an Unbelieving World: How the Early Church Engaged Society

Standing before the Roman proconsul, Polycarp knew the end was near. The skilled Roman official methodically questioned him and repeatedly demanded that Polycarp worship a pagan image. Each time he refused. The bloodthirsty crowd filling the amphitheater jeered the Christian bishop. Changing tactics, the proconsul encouraged Polycarp to persuade the people. Polycarp felt no compulsion…

Read More